(Q42135660)

17 October 2017

Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure (English)

1 reference

7 November 2022

1 reference

7 November 2022

congestive heart failure

1 reference

V. Klauss

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1719270

7 November 2022

W. Zwehl

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1719270

7 November 2022

H. Mudra

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1719270

7 November 2022

R. Huber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1719270

7 November 2022

R. Schmidt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1719270

7 November 2022

M. Scheininger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1719270

7 November 2022

A. Vogler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1719270

7 November 2022

O. Tschaidse

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1719270

7 November 2022

H. A. Dieterich

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1719270

7 November 2022

K. Theisen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1719270

7 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1719270

7 November 2022

publication date

1 July 1991

1 reference

17 October 2017

22 July 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1719270

full work available at URL

7 November 2022

http://link.springer.com/content/pdf/10.1007/BF01666828.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01666828/fulltext.html

7 November 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF01666828

7 November 2022

1 reference

7 November 2022

published in

Klinische Wochenschrift

1 reference

17 October 2017

69

1 reference

17 October 2017

10

1 reference

17 October 2017

430-435

1 reference

Inotropic therapy for refractory congestive heart failure with oral fenoximone (MDL-17,043): poor long-term results despite early hemodynamic and clinical improvement

17 October 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01666828

Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01666828

[Effect of oral long-term enoximone therapy on the arrhythmia profile in chronic heart failure]

21 January 2018

1 reference

12 December 2020

Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance

1 reference

12 December 2020

Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure

1 reference

12 December 2020

Differential hemodynamic effects of oral enoximone in severe congestive heart failure

1 reference

12 December 2020

Determination of anaerobic threshold for assessment of functional state in patients with chronic heart failure

1 reference

12 December 2020

The anaerobic threshold in chronic heart failure. Relation to blood lactate, ventilatory basis, reproducibility, and response to exercise training

1 reference

12 December 2020

Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patients

1 reference

12 December 2020

Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure

1 reference

12 December 2020

Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure

1 reference

12 December 2020

Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure

1 reference

12 December 2020

Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure

1 reference

12 December 2020

MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure.

1 reference

12 December 2020

The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias

1 reference

12 December 2020

Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure

1 reference

12 December 2020

Physiologic response to the inotropic and vasodilator properties of enoximone

1 reference

12 December 2020

Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).

1 reference

12 December 2020

Abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure

1 reference

12 December 2020

The Role of Cyclic Adenosine Monophosphate in Adrenergic Effects on Ventricular Vulnerability to Fibrillation in the Isolated Perfused Rat Heart

1 reference

12 December 2020

Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group

1 reference

12 December 2020

A comparison of methodologies in detection of the anaerobic threshold

1 reference

12 December 2020

Disparity between improvement in left ventricular function and changes in clinical status and exercise capacity during chronic enoximone therapy

1 reference

12 December 2020

Effects of new inotropic agents on exercise performance

1 reference

12 December 2020

Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure

1 reference

12 December 2020

A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure

1 reference

12 December 2020

Why patients with congestive heart failure die: arrhythmias and sudden cardiac death

1 reference

12 December 2020

Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01666828

1 reference

17 October 2017

1 reference